Authors

Silvano Gallus, Istituto di Ricerche Farmacologiche Mario Negri
Alessandra Lugo, Istituto di Ricerche Farmacologiche Mario Negri
Xiaoqiu Liu, 2 Institute of Public Health of the American College of Greece
Panagiotis Behrakis, 2 Institute of Public Health of the American College of Greece
Roberto Boffi, Istituto di Ricerche Farmacologiche Mario Negri
Cristina Bosetti, Istituto di Ricerche Farmacologiche Mario Negri
Giulia Carreras, 5 Istituto per lo Studio, la Prevenzione e la Rete Oncologica
Liliane Chatenoud, Istituto di Ricerche Farmacologiche Mario Negri IRCCS,
Luke Clancy, Technological University DublinFollow
Xavier Continente, Agència de Salut Pública de Barcelona
Ruaraidh Dobson, University of Stirling
Tobias Effertz, University of Hambourg
Filippos T. Filippidis, Imperial College London
Marcela Fu, Institut Català d’Oncologia, L’Hospitalet de Llobregat
Gergana Geshanova, Smoke Free Life Coalition
Giuseppe Gorini, Istituto per lo Studio, la Prevenzione e la Rete Oncologica
Sheila Keogan, Technological University DublinFollow
Hristo Ivanov, Smoke Free Life Coalition
Maria J. Lopez, Agència de Salut Pública de Barcelona
Angel Lopez-Nicolas, Universidad Politécnica de Cartagena
Jose Precioso, Universidade do Minho, Braga
Krzysztof Przewozniak, 1Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw
Cornel Radu-Loghin, 4European Network for Smoking Prevention, Bruxelles
Ario Ruprecht, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Sean Semple, University of Stirling
Joan B. Soriano, Consortium for Biomedical Research in Respiratory Diseases (CIBER en Enfermedades Respiratorias, CIBERES)
Polina Starchenko, European Network for Smoking Prevention, Bruxelles
Marta Trapero-Bertran, Universitat Internacional de Catalunya (UIC
Olena Tigova, Institut Català d’Oncologia, L’Hospitalet de Llobregat
Anna S. Tzortzi, Institute of Public Health of the American College of Greece
Constantine Vardavas, Institute of Public Health of the American College of Greece
Vergina K. Vyzikidou, Institute of Public Health of the American College of Greece
Paola Colombo, DOXA Institute, Milan
Esteve Fernandez, Institut Català d’Oncologia, L’Hospitalet de Llobregat
TackSHS Project Investigators

Document Type

Article

Rights

This item is available under a Creative Commons License for non-commercial use only

Disciplines

1.6 BIOLOGICAL SCIENCES

Publication Details

Journal of Epidemiology

Abstract

Background: Population data on tobacco use and its determinants require continuous monitoring and careful inter-country comparison. We aimed to provide the most up-to-date estimates on tobacco smoking from a large cross-sectional survey, conducted in selected European countries.

Methods: Within the TackSHS Project, a face-to-face survey on smoking was conducted in 2017–2018 in 12 countries: Bulgaria, England, France, Germany, Greece, Ireland, Italy, Latvia, Poland, Portugal, Romania, and Spain, representing around 80% of the 432 million European Union (EU) adult population. In each country, a representative sample of around 1,000 subjects aged 15 years and older was interviewed, for a total of 11,902 participants.

Results: Overall, 25.9% of participants were current smokers (31.0% of men and 21.2% of women, P < 0.001), while 16.5% were former smokers. Smoking prevalence ranged from 18.9% in Italy to 37.0% in Bulgaria. It decreased with increasing age (compared to <45, multivariable odds ratio [OR] for ≥65 year, 0.31; 95% confidence interval [CI], 0.27–0.36), level of education (OR for low vs high, 1.32; 95% CI, 1.17–1.48) and self-rated household economic level (OR for low vs high, 2.05; 95% CI, 1.74–2.42). The same patterns were found in both sexes.

Conclusions: These smoking prevalence estimates represent the most up-to-date evidence in Europe. From them, it can be derived that there are more than 112 million current smokers in the EU-28. Lower socio-economic status is a major determinant of smoking habit in both sexes.

DOI

https://doi.org/10.2188/JE20190344

Share

COinS